Community Perspectives Associated With the African PsA-TT (MenAfriVac) Vaccine Trials

Background. The Meningitis Vaccine Project (MVP) was established to address epidemic meningitis as a public health problem in sub-Saharan Africa and, to that end, worked to develop a group A meningococcal conjugate vaccine, PsA-TT. Methods. Experiences in 4 clinical trial sites are described. Cultur...

Descripción completa

Detalles Bibliográficos
Autores principales: Idoko, Olubukola T., Diallo, Aldiouma, Sow, Samba O., Hodgson, Abraham, Akinsola, Adebayo, Diarra, Bou, Haidara, Fadima Cheick, Ansah, Patrick Odum, Kampmann, Beate, Bouma, Enricke, Preziosi, Marie-Pierre, Enwere, Godwin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639498/
https://www.ncbi.nlm.nih.gov/pubmed/26553669
http://dx.doi.org/10.1093/cid/civ596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639498/
https://www.ncbi.nlm.nih.gov/pubmed/26553669
http://dx.doi.org/10.1093/cid/civ596

Ejemplares similares